![]() |
|
|
Department of Life Sciences, University of Limerick, Limerick, Ireland
3To whom correspondence should be addressed. E-mail: E-mail:dick.fitzgerald{at}ul.ie.
Hypertension is the major controllable risk factor associated with cardiovascular disease (CVD) events such as myocardial infarction, stroke, heart failure, and end-stage diabetes. A 5 mm Hg decrease in blood pressure has been equated with
16% decrease in CVD. In the U.S. alone current annual antihypertensive drug costs are approximately $15 billion. The renin-angiotensin-aldosterone system is a target for blood pressure control. Cleavage of angiotensinogen by renin produces angiotensin I which is subsequently hydrolyzed by angiotensin-I-converting enzyme (ACE) to angiotensin II (a potent vasoconstrictor). Various side effects are associated with the use of ACE inhibitory drugs in the control of blood pressure including hypotension, increased potassium levels, reduced renal function, cough, angioedema, skin rashes, and fetal abnormalities. Milk proteins, both caseins and whey proteins, are a rich source of ACE inhibitory peptides. Several studies in spontaneously hypertensive rats show that these casokinins and lactokinins can significantly reduce blood pressure. Furthermore, a limited number of human studies have associated milk protein-derived peptides with statistically significant hypotensive effects (i.e., lower systolic and diastolic pressures). The advent of effective milk protein based functional food ingredients/nutraceuticals for the prevention/control of blood pressure therefore has the potential to significantly reduce global healthcare cost.
KEY WORDS: ACE inhibitors casokinins lactokinins hypertension functional foods
This article has been cited by other articles:
![]() |
W. Suhara, H. Koide, T. Okuzawa, D. Hayashi, T. Hashimoto, and H. Kojo Cow's milk increases the activities of human nuclear receptors peroxisome proliferator-activated receptors {alpha} and {delta} and retinoid X receptor {alpha} involved in the regulation of energy homeostasis, obesity, and inflammation J Dairy Sci, September 1, 2009; 92(9): 4180 - 4187. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Enomoto, Y. Hayashi, C. P. Li, S. Ohki, H. Ohtomo, M. Shiokawa, and T. Aoki Glycation and phosphorylation of {alpha}-lactalbumin by dry heating: Effect on protein structure and physiological functions J Dairy Sci, July 1, 2009; 92(7): 3057 - 3068. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weimann, H. Meisel, and G. Erhardt Short communication: Bovine {kappa}-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides J Dairy Sci, May 1, 2009; 92(5): 1885 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Foltz, E. E. Meynen, V. Bianco, C. van Platerink, T. M. M. G. Koning, and J. Kloek Angiotensin Converting Enzyme Inhibitory Peptides from a Lactotripeptide-Enriched Milk Beverage Are Absorbed Intact into the Circulation J. Nutr., April 1, 2007; 137(4): 953 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Geerlings, I. C. Villar, F. H. Zarco, M. Sanchez, R. Vera, A. Z. Gomez, J. Boza, and J. Duarte Identification and characterization of novel Angiotensin-converting enzyme inhibitors obtained from goat milk. J Dairy Sci, September 1, 2006; 89(9): 3326 - 3335. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Huth, D. B. DiRienzo, and G. D. Miller Major scientific advances with dairy foods in nutrition and health. J Dairy Sci, April 1, 2006; 89(4): 1207 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alonso, J. J. Beunza, M. Delgado-Rodriguez, J A. Martinez, and M. A. Martinez-Gonzalez Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort Am. J. Clinical Nutrition, November 1, 2005; 82(5): 972 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun and M. B. Zemel Calcium and Dairy Products Inhibit Weight and Fat Regain during Ad Libitum Consumption Following Energy Restriction in Ap2-Agouti Transgenic Mice J. Nutr., November 1, 2004; 134(11): 3054 - 3060. [Abstract] [Full Text] [PDF] |
||||